摘要
随着超声检查和乳腺穿刺组织学检查在乳腺诊疗中日渐普及,对于BI-RADS-3类乳腺肿物中具有潜在恶性风险的病变,早期的识别,早期干预显得尤为重要。其中导管内乳头状瘤(Intraductal papillomas, IPs)是这组疾病中常见的病理类型。随其组织学表现为良性,但IPs具有潜在恶性,并且实际诊疗中易低估其进展为乳腺恶性肿瘤的风险。本文总结、分析了当前文献中对于IPs早期诊断及管理的共识与争议。事实表明,并不一定要向所有IPs患者推荐开放性手术。因此,乳腺外科医生,对于患者的早期识别诊断,对患者的分类管理至关重要。
With the popularity of ultrasound and mammary gland puncture biopsy in breast diagnosis and treatment, for BI-RADS-3 kinds of breast neoplasm with the risk of potentially malignant lesions, early identification and early intervention are important. Intraductal papillomas (IPs) are the common pathological types of the group of diseases. With the histological expression it is benign, but IPs are potentially malignant, and it is easy to underestimate the actual diagnosis and treat-ment to the risk of breast malignant tumors. This article summarizes and analyzes the consensus and controversy in current literature for early diagnosis and management of IPs. In fact, does not have to recommend open surgery to all patients with IPs. Therefore, breast surgeon, for early iden-tification of patients with diagnosis, classification management of patients is very important.
出处
《临床医学进展》
2022年第9期8559-8562,共4页
Advances in Clinical Medicine